Von Willebrand Disease as a Common Yet Under-Recognised Bleeding Disorder – EHC
European Haemophilia Consortium (EHC) shared a post on LinkedIn:
“Von Willebrand Disease (VWD) is one of the most common inherited bleeding disorders — yet it has remained under-recognised for 100 years.
While VWD affects men and women equally, women often experience the greatest impact: heavy menstrual bleeding, prolonged healing, and symptoms that are too often normalised or overlooked.
As part of our VWD 100 campaign, we’re proud to share this newly adapted video, originally created by the French Reference Centre for VWD (CRMW) in partnership with French Association of Hemophiliacs and MHEMO, the national French network for rare haemostasis diseases.
We are grateful to them for allowing us to bring this resource to a wider audience.
This is just one chapter of our year-long campaign shining a light on every facet of VWD throughout 2026.
This is just one chapter of our year-long campaign shining a light on every facet of VWD throughout 2026.”
Stay updated with Hemostasis Today.
-
Sep 23, 2026, 00:08Janar Sathananthan: The Importance of Durable Drug Delivery in DCB Therapy
-
Sep 23, 2026, 00:07Arun V J: How Does a Good Conference Destroy My Ego?
-
Sep 23, 2026, 00:06Akshat Jain: Sickle Cell Disease Is Not One Size Fits All
-
Sep 23, 2026, 00:05Sherri Ozawa: Nicole De Vita’s Iron Deficiency Infographic Recognized at SABM
-
Sep 23, 2026, 00:04Zafar Ali: How Does Hemoglobin Know When to Hold Oxygen and When to Let It Go?
-
Sep 23, 2026, 00:02Ahmed Elsharkawy: Drug-Drug and Drug-Diluent Incompatibilities in ICUs and Hematology Units
-
Sep 22, 2026, 23:58Nishant Rajendra Tiwari: Hereditary TTP With the Same ADAMTS13 Variants but Strikingly Different Disease Courses
-
Sep 22, 2026, 23:57Akhil Santhosh: Pacritinib Versus Ruxolitinib in Myelofibrosis With Thrombocytopenia
-
Sep 22, 2026, 23:56Nathan Punwani: EASIX and sC5b-9 Predict TMA After Allogeneic Stem Cell Transplantation